Todd Beechey

Todd Beechey, as Vice President of Finance and Business Development at Septodont, plays a pivotal role in shaping the company's strategic direction and driving sustainable growth within the North American dental pharmaceutical market. With over two decades of management experience across diverse industries, Todd leverages his extensive expertise in financial planning, forecasting, and operational management to support Septodont’s mission of delivering innovative dental anesthetics and material products. His current responsibilities encompass overseeing financial performance across Septodont’s three operating entities—Septodont, Novocol Pharmaceutical Division, and Confi-Dental Division—ensuring robust financial health and operational efficiency.

A key focus for Todd is identifying new business opportunities and fostering strategic partnerships that align with Septodont’s growth objectives. His proficiency in business development, combined with a deep understanding of manufacturing processes and change management, enables him to lead cross-functional teams effectively, implement process improvements, and optimize resource allocation. Todd’s strategic planning skills are instrumental in developing long-term business strategies, managing budgets, and executing initiatives that enhance market share and operational excellence.

In addition to his financial acumen, Todd actively participates in product innovation and market expansion efforts, ensuring Septodont remains a leader in dental anesthetics and related products. His collaborative leadership style and ability to navigate complex regulatory and industry landscapes make him a valuable asset in driving Septodont’s continued success and maintaining its competitive edge in the dental healthcare industry.